25 XP   0   0   10

Hunan Jiudian Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Hunan Jiudian Pharmaceutical Co Ltd together

PenkeI guess you are interested in Hunan Jiudian Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hunan Jiudian Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hunan Jiudian Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hunan Jiudian Pharmaceutical Co Ltd.

Quick analysis of Hunan Jiudian Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Hunan Jiudian Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.11
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.50
Expected worth in 1 year
¥9.75
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥6.06
Return On Investment
17.3%

For what price can you sell your share?

Current Price per Share
¥34.95
Expected price per share
¥25.80 - ¥39.00
How sure are you?
50%

1. Valuation of Hunan Jiudian Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥34.95

Intrinsic Value Per Share

¥-3.95 - ¥-0.25

Total Value Per Share

¥0.55 - ¥4.25

2. Growth of Hunan Jiudian Pharmaceutical Co Ltd (5 min.)




Is Hunan Jiudian Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$214.5m$151.9m$62.6m29.2%

How much money is Hunan Jiudian Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$37.2m$28.2m$9m24.3%
Net Profit Margin11.6%12.5%--

How much money comes from the company's main activities?

3. Financial Health of Hunan Jiudian Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Hunan Jiudian Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Hunan Jiudian Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Hunan Jiudian Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Hunan Jiudian Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Hunan Jiudian Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hunan Jiudian Pharmaceutical Co Ltd is ¥34.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hunan Jiudian Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hunan Jiudian Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.50. Based on the TTM, the Book Value Change Per Share is ¥1.31 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.76 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.20 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hunan Jiudian Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.110.3%0.110.3%0.080.2%0.050.2%0.050.1%
Usd Book Value Change Per Share0.180.5%0.180.5%0.110.3%0.070.2%0.090.3%
Usd Dividend Per Share0.030.1%0.030.1%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.210.6%0.210.6%0.110.3%0.080.2%0.100.3%
Usd Price Per Share3.36-3.36-4.86-3.05-2.69-
Price to Earnings Ratio31.10-31.10-59.38-67.24-66.82-
Price-to-Total Gains Ratio16.05-16.05-43.52-58.39-52.93-
Price to Book Ratio5.40-5.40-11.03-7.74-7.48-
Price-to-Total Gains Ratio16.05-16.05-43.52-58.39-52.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.83009
Number of shares207
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.180.07
Usd Total Gains Per Share0.210.08
Gains per Quarter (207 shares)43.3116.93
Gains per Year (207 shares)173.2667.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12315016395958
24630133617118126
36945150926178194
49260168234237262
511575185543296330
6138902102851355398
71611052120160414466
81841202137468473534
92071353154777533602
102301503172086592670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Hunan Jiudian Pharmaceutical Co Ltd

About Hunan Jiudian Pharmaceutical Co Ltd

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its leading products are loxoprofen sodium gel plaster and hydrochloric acid. The company offers its products in the anti-inflammatory and analgesic, anti-infective, anti-allergic, digestive system, cardiovascular and cerebrovascular, gynecological drugs, supplements, and other fields. The company was founded in 2001 and is based in Changsha, China.

Fundamental data was last updated by Penke on 2024-04-01 20:01:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hunan Jiudian Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hunan Jiudian Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hunan Jiudian Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 11.6% means that ¥0.12 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 11.6%. The company is making a huge profit. +2
  • The TTM is 11.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.6%TTM11.6%0.0%
TTM11.6%YOY12.5%-1.0%
TTM11.6%5Y9.5%+2.1%
5Y9.5%10Y10.7%-1.2%
1.1.2. Return on Assets

Shows how efficient Hunan Jiudian Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hunan Jiudian Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.7% Return on Assets means that Hunan Jiudian Pharmaceutical Co Ltd generated ¥0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 11.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 11.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ11.7%TTM11.7%0.0%
TTM11.7%YOY11.7%+0.0%
TTM11.7%5Y8.7%+3.0%
5Y8.7%10Y9.4%-0.8%
1.1.3. Return on Equity

Shows how efficient Hunan Jiudian Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hunan Jiudian Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 17.4% Return on Equity means Hunan Jiudian Pharmaceutical Co Ltd generated ¥0.17 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 17.4%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.4%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.4%TTM17.4%0.0%
TTM17.4%YOY18.6%-1.2%
TTM17.4%5Y12.6%+4.8%
5Y12.6%10Y12.9%-0.3%

1.2. Operating Efficiency of Hunan Jiudian Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hunan Jiudian Pharmaceutical Co Ltd is operating .

  • Measures how much profit Hunan Jiudian Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hunan Jiudian Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 12.0% means the company generated ¥0.12  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 12.0%. The company is operating less efficient.
  • The TTM is 12.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ12.0%TTM12.0%0.0%
TTM12.0%YOY13.0%-1.0%
TTM12.0%5Y9.6%+2.4%
5Y9.6%10Y11.7%-2.1%
1.2.2. Operating Ratio

Measures how efficient Hunan Jiudian Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are ¥1.08 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 1.084. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.084. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.084TTM1.0840.000
TTM1.084YOY1.057+0.027
TTM1.0845Y1.167-0.083
5Y1.16710Y1.213-0.046

1.3. Liquidity of Hunan Jiudian Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hunan Jiudian Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.72 means the company has ¥2.72 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 2.715. The company is able to pay all its short-term debts. +1
  • The TTM is 2.715. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.715TTM2.7150.000
TTM2.715YOY2.755-0.039
TTM2.7155Y2.697+0.019
5Y2.69710Y3.317-0.620
1.3.2. Quick Ratio

Measures if Hunan Jiudian Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hunan Jiudian Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.23 means the company can pay off ¥1.23 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 1.234. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.234. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.234TTM1.2340.000
TTM1.234YOY1.046+0.188
TTM1.2345Y0.983+0.251
5Y0.98310Y1.078-0.094

1.4. Solvency of Hunan Jiudian Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hunan Jiudian Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hunan Jiudian Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32 means that Hunan Jiudian Pharmaceutical Co Ltd assets are financed with 32.5% credit (debt) and the remaining percentage (100% - 32.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 0.325. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.325. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.325TTM0.3250.000
TTM0.325YOY0.370-0.045
TTM0.3255Y0.297+0.028
5Y0.29710Y0.259+0.038
1.4.2. Debt to Equity Ratio

Measures if Hunan Jiudian Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hunan Jiudian Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 48.1% means that company has ¥0.48 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The MRQ is 0.481. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.481. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.481TTM0.4810.000
TTM0.481YOY0.588-0.106
TTM0.4815Y0.428+0.053
5Y0.42810Y0.362+0.066

2. Market Valuation of Hunan Jiudian Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hunan Jiudian Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hunan Jiudian Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 31.10 means the investor is paying ¥31.10 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The EOD is 44.727. Based on the earnings, the company is overpriced. -1
  • The MRQ is 31.098. Based on the earnings, the company is overpriced. -1
  • The TTM is 31.098. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD44.727MRQ31.098+13.629
MRQ31.098TTM31.0980.000
TTM31.098YOY59.381-28.284
TTM31.0985Y67.240-36.142
5Y67.24010Y66.824+0.416
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The EOD is -83.542. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -58.085. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -58.085. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-83.542MRQ-58.085-25.457
MRQ-58.085TTM-58.0850.000
TTM-58.085YOY186.753-244.838
TTM-58.0855Y37.976-96.060
5Y37.97610Y-47.200+85.176
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hunan Jiudian Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Hunan Jiudian Pharmaceutical Co Ltd:

  • The EOD is 7.769. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.402. Based on the equity, the company is overpriced. -1
  • The TTM is 5.402. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.769MRQ5.402+2.367
MRQ5.402TTM5.4020.000
TTM5.402YOY11.032-5.631
TTM5.4025Y7.742-2.340
5Y7.74210Y7.482+0.260
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hunan Jiudian Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.3131.3130%0.764+72%0.517+154%0.643+104%
Book Value Per Share--4.4984.4980%3.185+41%2.879+56%2.463+83%
Current Ratio--2.7152.7150%2.755-1%2.697+1%3.317-18%
Debt To Asset Ratio--0.3250.3250%0.370-12%0.297+9%0.259+26%
Debt To Equity Ratio--0.4810.4810%0.588-18%0.428+12%0.362+33%
Dividend Per Share--0.2010.2010%0.043+362%0.075+168%0.066+206%
Eps--0.7810.7810%0.592+32%0.396+97%0.334+134%
Free Cash Flow Per Share---0.418-0.4180%0.188-322%-0.167-60%-0.117-72%
Free Cash Flow To Equity Per Share---0.068-0.0680%1.010-107%0.090-175%0.168-140%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.247--------
Intrinsic Value_10Y_min---3.950--------
Intrinsic Value_1Y_max---0.011--------
Intrinsic Value_1Y_min---0.227--------
Intrinsic Value_3Y_max---0.044--------
Intrinsic Value_3Y_min---0.832--------
Intrinsic Value_5Y_max---0.089--------
Intrinsic Value_5Y_min---1.597--------
Market Cap12062817470.400+30%8387023305.6008387023305.6000%12128395018.880-31%7611144266.484+10%6725401631.900+25%
Net Profit Margin--0.1160.1160%0.125-8%0.095+22%0.107+8%
Operating Margin--0.1200.1200%0.130-8%0.096+25%0.117+3%
Operating Ratio--1.0841.0840%1.057+3%1.167-7%1.213-11%
Pb Ratio7.769+30%5.4025.4020%11.032-51%7.742-30%7.482-28%
Pe Ratio44.727+30%31.09831.0980%59.381-48%67.240-54%66.824-53%
Price Per Share34.950+30%24.30024.3000%35.140-31%22.052+10%19.486+25%
Price To Free Cash Flow Ratio-83.542-44%-58.085-58.0850%186.753-131%37.976-253%-47.200-19%
Price To Total Gains Ratio23.083+30%16.04916.0490%43.523-63%58.393-73%52.929-70%
Quick Ratio--1.2341.2340%1.046+18%0.983+26%1.078+15%
Return On Assets--0.1170.1170%0.117+0%0.087+35%0.094+24%
Return On Equity--0.1740.1740%0.186-7%0.126+38%0.129+35%
Total Gains Per Share--1.5141.5140%0.807+88%0.592+156%0.708+114%
Usd Book Value--214572173.124214572173.1240%151928453.354+41%137306420.848+56%117496734.515+83%
Usd Book Value Change Per Share--0.1810.1810%0.106+72%0.071+154%0.089+104%
Usd Book Value Per Share--0.6220.6220%0.440+41%0.398+56%0.340+83%
Usd Dividend Per Share--0.0280.0280%0.006+362%0.010+168%0.009+206%
Usd Eps--0.1080.1080%0.082+32%0.055+97%0.046+134%
Usd Free Cash Flow---19955097.452-19955097.4520%8975179.363-322%-7962605.204-60%-5560633.609-72%
Usd Free Cash Flow Per Share---0.058-0.0580%0.026-322%-0.023-60%-0.016-72%
Usd Free Cash Flow To Equity Per Share---0.009-0.0090%0.140-107%0.013-175%0.023-140%
Usd Market Cap1667081374.409+30%1159086620.8341159086620.8340%1676144191.609-31%1051860137.628+10%929450505.529+25%
Usd Price Per Share4.830+30%3.3583.3580%4.856-31%3.048+10%2.693+25%
Usd Profit--37272560.94437272560.9440%28226766.416+32%18885211.629+97%15919795.605+134%
Usd Revenue--321483032.924321483032.9240%224943295.012+43%184012649.295+75%149421676.720+115%
Usd Total Gains Per Share--0.2090.2090%0.112+88%0.082+156%0.098+114%
 EOD+5 -3MRQTTM+0 -0YOY+21 -145Y+26 -910Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Hunan Jiudian Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.727
Price to Book Ratio (EOD)Between0-17.769
Net Profit Margin (MRQ)Greater than00.116
Operating Margin (MRQ)Greater than00.120
Quick Ratio (MRQ)Greater than11.234
Current Ratio (MRQ)Greater than12.715
Debt to Asset Ratio (MRQ)Less than10.325
Debt to Equity Ratio (MRQ)Less than10.481
Return on Equity (MRQ)Greater than0.150.174
Return on Assets (MRQ)Greater than0.050.117
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Hunan Jiudian Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.469
Ma 20Greater thanMa 5036.327
Ma 50Greater thanMa 10034.804
Ma 100Greater thanMa 20033.604
OpenGreater thanClose35.290
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,299,671
Total Liabilities747,050
Total Stockholder Equity1,552,621
 As reported
Total Liabilities 747,050
Total Stockholder Equity+ 1,552,621
Total Assets = 2,299,671

Assets

Total Assets2,299,671
Total Current Assets1,206,495
Long-term Assets1,093,177
Total Current Assets
Cash And Cash Equivalents 345,843
Short-term Investments 90,256
Net Receivables 458,195
Inventory 241,039
Other Current Assets 23,004
Total Current Assets  (as reported)1,206,495
Total Current Assets  (calculated)1,158,338
+/- 48,157
Long-term Assets
Property Plant Equipment 892,285
Intangible Assets 100,266
Other Assets 79,234
Long-term Assets  (as reported)1,093,177
Long-term Assets  (calculated)1,071,786
+/- 21,391

Liabilities & Shareholders' Equity

Total Current Liabilities444,345
Long-term Liabilities302,706
Total Stockholder Equity1,552,621
Total Current Liabilities
Short Long Term Debt 71,568
Accounts payable 143,796
Other Current Liabilities 157,830
Total Current Liabilities  (as reported)444,345
Total Current Liabilities  (calculated)373,193
+/- 71,151
Long-term Liabilities
Long term Debt 231,488
Capital Lease Obligations Min Short Term Debt148
Other Liabilities 71,070
Deferred Long Term Liability 10,731
Long-term Liabilities  (as reported)302,706
Long-term Liabilities  (calculated)313,437
+/- 10,731
Total Stockholder Equity
Common Stock342,936
Retained Earnings 724,817
Total Stockholder Equity (as reported)1,552,621
Total Stockholder Equity (calculated)1,067,753
+/- 484,867
Other
Capital Stock342,936
Common Stock Shares Outstanding 342,936
Net Invested Capital 1,855,677
Net Tangible Assets 1,460,963
Net Working Capital 762,150
Property Plant and Equipment Gross 892,285



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
397,033
769,203
943,211
1,072,099
1,130,720
1,745,237
2,299,671
2,299,6711,745,2371,130,7201,072,099943,211769,203397,033
   > Total Current Assets 
234,607
518,693
465,915
454,178
503,604
1,020,272
1,206,495
1,206,4951,020,272503,604454,178465,915518,693234,607
       Cash And Cash Equivalents 
70,799
298,429
170,556
131,578
135,258
398,405
345,843
345,843398,405135,258131,578170,556298,42970,799
       Short-term Investments 
0
0
0
0
0
100,314
90,256
90,256100,31400000
       Net Receivables 
80,722
120,706
154,715
148,995
164,284
287,047
458,195
458,195287,047164,284148,995154,715120,70680,722
       Inventory 
77,578
95,880
109,231
136,398
153,118
214,479
241,039
241,039214,479153,118136,398109,23195,88077,578
       Other Current Assets 
5,509
3,678
31,413
37,207
24,707
20,027
23,004
23,00420,02724,70737,20731,4133,6785,509
   > Long-term Assets 
162,425
250,510
477,296
617,921
627,116
724,965
1,093,177
1,093,177724,965627,116617,921477,296250,510162,425
       Property Plant Equipment 
137,818
173,761
404,555
535,637
533,149
606,828
892,285
892,285606,828533,149535,637404,555173,761137,818
       Intangible Assets 
17,436
52,045
52,865
52,141
51,062
77,355
100,266
100,26677,35551,06252,14152,86552,04517,436
       Other Assets 
7,172
24,704
19,876
30,143
42,906
40,782
79,234
79,23440,78242,90630,14319,87624,7047,172
> Total Liabilities 
73,605
108,947
225,052
310,228
295,038
645,899
747,050
747,050645,899295,038310,228225,052108,94773,605
   > Total Current Liabilities 
72,221
79,950
157,132
200,544
180,960
370,376
444,345
444,345370,376180,960200,544157,13279,95072,221
       Short-term Debt 
20,000
4,000
50,000
65,000
0
0
0
00065,00050,0004,00020,000
       Short Long Term Debt 
20,000
4,000
50,000
65,000
10,400
53,766
71,568
71,56853,76610,40065,00050,0004,00020,000
       Accounts payable 
30,195
32,613
54,714
69,351
59,907
108,877
143,796
143,796108,87759,90769,35154,71432,61330,195
       Other Current Liabilities 
17,468
33,066
34,738
34,590
67,095
109,930
157,830
157,830109,93067,09534,59034,73833,06617,468
   > Long-term Liabilities 
1,384
28,997
67,919
109,684
114,078
275,523
302,706
302,706275,523114,078109,68467,91928,9971,384
       Capital Lease Obligations 
0
0
0
0
0
0
148
148000000
       Other Liabilities 
1,384
28,997
38,230
40,961
43,576
51,247
71,070
71,07051,24743,57640,96138,23028,9971,384
> Total Stockholder Equity
323,428
660,255
718,159
761,871
835,682
1,099,338
1,552,621
1,552,6211,099,338835,682761,871718,159660,255323,428
   Common Stock
88,000
117,340
234,680
234,680
234,680
234,687
342,936
342,936234,687234,680234,680234,680117,34088,000
   Retained Earnings 
78,216
146,789
204,693
248,405
322,216
516,370
724,817
724,817516,370322,216248,405204,693146,78978,216
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
0
0
0
0
0
69,307
0
069,30700000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,619,974
Cost of Revenue-586,400
Gross Profit-2,033,574
 
Operating Income (+$)
Gross Profit-
Operating Expense-2,187,641
Operating Income432,332-2,187,641
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense2,187,6410
 
Net Interest Income (+$)
Interest Income-
Interest Expense-8,317
Other Finance Cost-4,402
Net Interest Income-3,915
 
Pretax Income (+$)
Operating Income432,332
Net Interest Income-3,915
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-432,332
EBIT - interestExpense = -8,317
371,301
379,618
Interest Expense8,317
Earnings Before Interest and Taxes (EBIT)-8,317
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income371,301
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-3,915
 

Technical Analysis of Hunan Jiudian Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hunan Jiudian Pharmaceutical Co Ltd. The general trend of Hunan Jiudian Pharmaceutical Co Ltd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hunan Jiudian Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hunan Jiudian Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 39.00.

The bearish price targets are: 27.68 > 27.52 > 25.80.

Tweet this
Hunan Jiudian Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hunan Jiudian Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hunan Jiudian Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hunan Jiudian Pharmaceutical Co Ltd. The current macd is -0.09849213.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hunan Jiudian Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hunan Jiudian Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hunan Jiudian Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hunan Jiudian Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHunan Jiudian Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hunan Jiudian Pharmaceutical Co Ltd. The current adx is 14.61.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hunan Jiudian Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Hunan Jiudian Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hunan Jiudian Pharmaceutical Co Ltd. The current sar is 37.16.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hunan Jiudian Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hunan Jiudian Pharmaceutical Co Ltd. The current rsi is 45.47. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Hunan Jiudian Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHunan Jiudian Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hunan Jiudian Pharmaceutical Co Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hunan Jiudian Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hunan Jiudian Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHunan Jiudian Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hunan Jiudian Pharmaceutical Co Ltd. The current cci is -84.52169333.

Hunan Jiudian Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHunan Jiudian Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hunan Jiudian Pharmaceutical Co Ltd. The current cmo is -17.40879194.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hunan Jiudian Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHunan Jiudian Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hunan Jiudian Pharmaceutical Co Ltd. The current willr is -88.6214442.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hunan Jiudian Pharmaceutical Co Ltd Daily Williams %R ChartHunan Jiudian Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hunan Jiudian Pharmaceutical Co Ltd.

Hunan Jiudian Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hunan Jiudian Pharmaceutical Co Ltd. The current atr is 1.44758094.

Hunan Jiudian Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHunan Jiudian Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hunan Jiudian Pharmaceutical Co Ltd. The current obv is 102,583,839.

Hunan Jiudian Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHunan Jiudian Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hunan Jiudian Pharmaceutical Co Ltd. The current mfi is 28.52.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hunan Jiudian Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHunan Jiudian Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hunan Jiudian Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Hunan Jiudian Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hunan Jiudian Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.469
Ma 20Greater thanMa 5036.327
Ma 50Greater thanMa 10034.804
Ma 100Greater thanMa 20033.604
OpenGreater thanClose35.290
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hunan Jiudian Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hunan Jiudian Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hunan Jiudian Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hunan Jiudian Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hunan Jiudian Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hunan Jiudian Pharmaceutical Co Ltd.

Receive notifications about Hunan Jiudian Pharmaceutical Co Ltd in your mailbox!